Pathogenesis of Muscle Wasting in Cancer Cachexia: Targeted Anabolic and Anticatabolic Therapies

Current Opinion in Clinical Nutrition and Metabolic Care - United States
doi 10.1097/mco.0b013e328339fdd2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Targeting RAGE Prevents Muscle Wasting and Prolongs Survival in Cancer Cachexia

Journal of Cachexia, Sarcopenia and Muscle
OrthopedicsSports MedicinePhysiology
2020English

TLR/MyD88/XBP1 Signaling Axis Mediates Skeletal Muscle Wasting During Cancer Cachexia

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2019English

The Countermeasure for Cancer Cachexia Related Muscle Wasting Does Not Need to Be Muscle Hyperplasia

Acta Physiologica
Physiology
2019English

Eicosapentaenoic Acid and Oxypurinol in the Treatment of Muscle Wasting in a Mouse Model of Cancer Cachexia

PLoS ONE
Multidisciplinary
2012English

Activity of the Akt-Dependent Anabolic and Catabolic Pathways in Muscle and Liver Samples in Cancer-Related Cachexia

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2007English

MicroRNA-mRNA Co-Sequencing Identifies Transcriptional and Post-Transcriptional Regulatory Networks Underlying Muscle Wasting in Cancer Cachexia

2019English

Myostatin: Regulator of Muscle Wasting in Heart Failure and Treatment Target for Cardiac Cachexia

Circulation
Cardiovascular MedicinePhysiologyCardiology
2010English

Targeted Cancer Therapies

Chinese Journal of Cancer
2011English

Pantoprazole Blocks the JAK2/STAT3 Pathway to Alleviate Skeletal Muscle Wasting in Cancer Cachexia by Inhibiting Inflammatory Response

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy